Viral Envelope Evolution in Simian–HIV-Infected Neonate and Adult-Dam Pairs of Rhesus Macaques EE Giorgi, H Li, B Hora, GM Shaw, K Wagh, WB Williams Viruses 16 (7), 1014, 2024 | | 2024 |
Immunogenicity of Monovalent mRNA-1273 and BNT162b2 Vaccines in Children< 5 Years of Age T Dalapati, CA Williams, EE Giorgi, JH Hurst, S Herbek, JL Chen, ... Pediatrics, e2024066190, 2024 | | 2024 |
Quantifying how single dose Ad26. COV2. S vaccine efficacy depends on Spike sequence features CA Magaret, L Li, AC deCamp, M Rolland, M Juraska, BD Williamson, ... Nature Communications 15 (1), 2175, 2024 | | 2024 |
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features M Juraska, H Bai, AC deCamp, CA Magaret, L Li, K Gillespie, LN Carpp, ... Proceedings of the National Academy of Sciences 121 (4), e2308942121, 2024 | 2 | 2024 |
Enhancement of Neutralization Responses through Sequential Immunization of Stable Env Trimers Based on Consensus Sequences from Select Time Points by Mimicking Natural Infection M Wan, X Yang, J Sun, EE Giorgi, X Ding, Y Zhou, Y Zhang, W Su, ... International Journal of Molecular Sciences 24 (16), 12642, 2023 | | 2023 |
Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition KE Seaton, Y Huang, S Karuna, JR Heptinstall, C Brackett, K Chiong, ... EBioMedicine 93, 2023 | 9 | 2023 |
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials NN Mkhize, AEJ Yssel, H Kaldine, RT van Dorsten, AS Woodward Davis, ... PLoS Pathogens 19 (6), e1011469, 2023 | 9 | 2023 |
A germline-targeting chimpanzee SIV envelope glycoprotein elicits a new class of V2-apex directed cross-neutralizing antibodies F Bibollet-Ruche, RM Russell, W Ding, W Liu, Y Li, K Wagh, D Wrapp, ... Mbio 14 (1), e03370-22, 2023 | 3 | 2023 |
Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults KW Cohen, A Fiore-Gartland, SR Walsh, K Yusim, N Frahm, ML Elizaga, ... The Journal of Clinical Investigation 133 (4), 2023 | 6 | 2023 |
A novel HIV triple broadly neutralizing antibody (bNAb) combination-based passive immunization of infant rhesus macaques achieves durable protective plasma neutralization … S Dankwa, C Kosman, M Dennis, EE Giorgi, K Vuong, I Pahountis, ... bioRxiv, 2023.10. 09.561559, 2023 | 1 | 2023 |
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition PB Gilbert, Y Huang, AC deCamp, S Karuna, Y Zhang, CA Magaret, ... Nature Medicine 28 (9), 1924-1932, 2022 | 58 | 2022 |
Vertical HIV-1 transmission in the setting of maternal broad and potent antibody responses JJ Tu, A Kumar, EE Giorgi, J Eudailey, CC LaBranche, DR Martinez, ... Journal of Virology 96 (11), e00231-22, 2022 | 6 | 2022 |
Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial B Julg, KE Stephenson, K Wagh, SC Tan, R Zash, S Walsh, J Ansel, ... Nature medicine 28 (6), 1288-1296, 2022 | 68 | 2022 |
PP 3.12–00180 Distinct HIV-1 resistance profiles against bNAb in intact vs defective viral genomes EE Giorgi, P Khadka, E Benko, C Kovacs, R Goswami, GG Fouda, ... | | 2022 |
Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial KE Stephenson, B Julg, CS Tan, R Zash, SR Walsh, CP Rolle, ... Nature medicine 27 (10), 1718-1724, 2021 | 51 | 2021 |
Different evolutionary pathways of HIV-1 between fetus and mother perinatal transmission pairs indicate unique immune selection in fetuses MH Marichannegowda, M Mengual, A Kumar, EE Giorgi, JJ Tu, ... Cell Reports Medicine 2 (7), 2021 | 2 | 2021 |
HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens W Fischer, EE Giorgi, S Chakraborty, K Nguyen, T Bhattacharya, J Theiler, ... Cell host & microbe 29 (7), 1093-1110, 2021 | 86 | 2021 |
Effect of epitope variant co-delivery on the depth of CD8 T cell responses induced by HIV-1 conserved mosaic vaccines EG Wee, N Moyo, Z Hannoun, EE Giorgi, B Korber, T Hanke Molecular Therapy Methods & Clinical Development 21, 741-753, 2021 | 11 | 2021 |
Mutations that confer resistance to broadly-neutralizing antibodies define HIV-1 variants of transmitting mothers from that of non-transmitting mothers A Kumar, EE Giorgi, JJ Tu, DR Martinez, J Eudailey, M Mengual, ... PLoS Pathogens 17 (4), e1009478, 2021 | 8 | 2021 |
Recombination and low-diversity confound homoplasy-based methods to detect the effect of SARS-CoV-2 mutations on viral transmissibility EE Giorgi, T Bhattacharya, W Fischer, H Yoon, W Abfalterer, B Korber bioRxiv, 2021.01. 29.428535, 2021 | 6 | 2021 |